SDShiyu Du

Shiyu Du

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shiyu Du has a total of 143 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Data-Driven Comorbidity Phenotypes and In-Hospital Outcomes Among Patients With Nonvariceal Upper Gastrointestinal Bleeding: Formative Retrospective Cohort Study

    by Fangning Wang, Yuhang Zhou, Qin Zhang, Yuan Liu, Yanli Zhang, Shiyu Du

    Background: Existing risk scores for nonvariceal upper gastrointestinal bleeding (NVUGIB) may not adequately represent the heterogeneity of coexisting chronic conditions. Routinely collected hospital discharge records may enable data-driven characterization of clinically meaningful comorbidity profiles. Objective: This formative study aimed to identify reproducible comorbidity profiles among patients hospitalized with NVUGIB and examine their associations with in-hospital outcomes and health care use. Methods: We conducted a retrospective cohort study of 3193 adults hospitalized with NVUGIB at a tertiary hospital in China between 2015 and 2025. Of 55 prespecified chronic conditions, 33 with a prevalence of at least 1% were included as binary clustering variables. Patients were randomly divided into an 80% training subset and a 20% held-out validation subset. Comorbidity profiles were identified in the training subset using a self-organizing map and Ward hierarchical clustering and then assigned to the validation subset using the fixed clustering solution. Profile reproducibility was evaluated by comparing condition prevalence vectors between subsets. Multivariable regression models assessed associations with severe in-hospital outcomes, intensive care unit admission, in-hospital death, length of stay, and hospital costs. Results: At least 1 selected comorbidity was recorded in 89.7% (2864/3193) of patients. Six profiles were identified: low-burden heterogeneous (cluster 1), non–upper gastrointestinal neoplastic-metastatic (cluster 2), circulatory-renal (cluster 3), cardiometabolic-renal (cluster 4), atherosclerotic-vascular (cluster 5), and rheumatologic-neurological (cluster 6). Profile composition was broadly reproducible between the training and validation subsets (weighted mean Spearman correlation=0.891, SD 0.04; P =.001). The circulatory-renal profile had the strongest associations with severe in-hospital outcomes (adjusted odds ratio [aOR] 8.57, 95% CI 5.39-14.01), intensive care unit admission (aOR 10.38, 95% CI 4.87-25.76), and in-hospital death (aOR 4.66, 95% CI 1.97-13.75). The rheumatologic-neurological and cardiometabolic-renal profiles were also associated with higher odds of these outcomes. All 6 profiles were associated with longer hospital stays and higher hospital costs. Conclusions: Using routinely collected hospital discharge records, we identified clinically interpretable comorbidity profiles among patients with NVUGIB. The profiles were broadly reproducible within the study population and showed different associations with clinical outcomes and resource use. Profile-based information may complement established risk assessment and could be examined further as an electronic health record–based approach to clinical management and resource planning.

  • Open Access

    Comparative Analysis of Overall Survival and Cancer-Specific Survival Between Endoscopic Therapy and Surgical Resection for Gastrointestinal Stromal Tumors

    by Shuo Chen, Geng Qin, Yingying Xu, Qingrui Zhang, Fang Liu, Shiyu Du

    Background/Aims: Few studies have compared endoscopic therapy (ET) with surgical resection for gastrointestinal stromal tumors (GISTs) measuring 2 to 10 cm in terms of overall survival and cancer-specific survival (CSS). This retrospective cohort study aimed to address this gap using data from the Surveillance, Epidemiology, and End Results (SEER) database. Materials and Methods: Data were extracted from the SEER database for patients with GIST who underwent ET or surgical resection between 2007 and 2021. Survival differences were assessed using Kaplan–Meier curves and log‑rank tests. Multivariable Cox proportional hazards models and 1 : 1 propensity score matching (propensity score matching [PSM], caliper = 0.02) were used to adjust for potential confounders. Results: A total of 3471 patients (394 in the ET group and 3077 in the surgery group) were included. Before PSM, the 5- and 10-year overall survival (OS) rates were 84.11% (95% CI: 79.41%-89.10%) and 66.03% (95% CI: 57.96%-75.22%), respectively, in the ET group, compared with 86.00% (95% CI: 84.40%-87.70%) and 69.31% (95% CI: 66.15%-72.61%), respectively, in the surgery group. CSS showed similar patterns. After adjustment for confounders, ET was not significantly associated with OS (hazard ratios [HR] = 1.238, 95% CI: 0.934-1.639, P = .137) or CSS (HR = 0.932, 95% CI: 0.510-1.702, P = .818). PSM yielded comparable OS and CSS between the 2 treatment groups. Conclusion: In a PSM cohort from the SEER database, ET was associated with overall survival and CSS comparable with that of surgical resection. However, these findings are hypothesis generating and require validation in prospective studies incorporating more detailed oncologic outcomes (R0 resection status, tumor rupture, recurrence, or adverse events, etc.). ET may be considered for carefully selected GISTs when performed by experienced endoscopists after thorough tumor assessment; however, these exploratory findings should not be interpreted as a treatment recommendation. Cite this article as: Chen S, Qin G, Xu Y, Zhang Q, Liu F, Du S. Comparative analysis of overall survival and cancer-specific survival between endoscopic therapy and surgical resection for gastrointestinal stromal tumors. Turk J Gastroenterol. Published online September 14, 2026. doi: 10.5152/tjg.2026.26042.

  • Retraction
    Open Access

    [Retracted] Characterization of sonic hedgehog inhibition in gastric carcinoma cells

    by Ruxue Bai, Hongchuan Zhao, Xiang Zhang, Shiyu Du

    Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

  • Open Access

    Sex-related molecular phenotypes in anxiety-depressive disorders: a machine learning analysis of routine blood biomarkers

    by Weizhe Zhen, Jingjing Chen, Hongjun Zhen, Yanli Zhang, Shiyu Du, Weihe Zhang, Dantao Peng

    Background: Anxiety disorders and depressive disorders are the most prevalent mental disorders worldwide. Their diagnosis has long relied on clinical symptom assessment, and objective blood−based biomarkers remain lacking. Sex is a critical risk factor for these disorders; however, sex−specific divergence in blood biochemical profiles has yet to be systematically characterized. Methods: This retrospective study enrolled 778 patients diagnosed with anxiety−depressive state at China−Japan Friendship Hospital. Demographic data, complete blood count parameters, and blood biochemical parameters were collected. Following missing value processing and multiple imputation, Mann–Whitney U tests were applied to identify sex−differentially expressed biomarkers. A random forest classifier was constructed to evaluate the discriminative capacity of combined multi−marker panels, with model performance comprehensively assessed through receiver operating characteristic curve analysis, SHAP−based explainability analysis, and multi−classifier probability projection. Age−stratified analyses were performed with a threshold of 50 years to explore the potential modifying effect of age on sex differences. Results: Several biomarkers exhibiting significant differences between males and females were identified (FDR < 0.05), among which creatinine, hemoglobin, hematocrit, red blood cell count, and uric acid demonstrated the largest effect sizes. The random forest model achieved an area under the receiver operating characteristic curve of 0.902 on the independent test set. Multi−classifier probability projection following hyperparameter tuning yielded a Silhouette coefficient of 0.464 in the two−dimensional space, with permutational multivariate analysis of variance confirming highly significant centroid differences between groups (p < 0.001). Age−stratified analysis using hemoglobin as an example revealed that levels in males were significantly higher than those in females across both age strata, with the magnitude of the sex difference attenuated in the ≥50−year group compared with the <50−year group. Conclusions: Robust sex−related signals are embedded in routine blood biochemical markers. Although complete separation is difficult to achieve under unsupervised dimensionality reduction, these signals can be efficiently integrated through ensemble learning algorithms. This study provides a molecular phenotypic basis related to sex in patients with anxiety−depressive state and underscores the importance of fully considering sex as a variable in clinical laboratory testing.

  • Open Access

    Lactylation shields S100A11 from degradation to promote gastric cancer metastasis

    by Qingrui Zhang, Yuhang Zhou, Fangning Wang, Jingrui Yan, Jiayu Liu, Lin Zhang, Shiyu Du

    Background: Protein lactylation, a novel post-translational modification utilizing lactate as the substrate, has emerged as a key mechanism linking metabolic alterations to cancer progression. This study aims to investigate the role and underlying mechanism of S100A11 lactylation in gastric cancer progression and metastasis. Methods: Lactylome profiling, site-directed mutagenesis, co-IP, cycloheximide chase, ubiquitination assays, and in vitro/in vivo functional experiments were performed to dissect the regulatory effect of S100A11 lactylation. Results: S100A11 was identified as a hyperlactylated protein in gastric cancer tissues, with lysine 27 (K27) and lysine 55 (K55) serving as the primary modification sites. Mechanistically, lactylation at K27 and K55 disrupted the interaction between S100A11 and its E3 ubiquitin ligase FBXW11, thereby inhibiting polyubiquitination and proteasomal degradation of the protein. The K27R/K55R double mutation, which abolished both lactylation and ubiquitination at these residues, resulted in constitutive stabilization of S100A11. The stabilized S100A11 hyperactivated the PI3K-AKT and ERK1/2 signaling cascades and upregulated the downstream oncogenic effectors Cyclin D1 and c-Myc. Functionally, S100A11 stabilization significantly enhanced the proliferation, colony formation, migration and invasion of gastric cancer cells in vitro, and markedly promoted lung metastasis in vivo. Clinically, higher lactylation levels of S100A11 were observed in patients with advanced TNM stages. Conclusion: This study reveals a lactylation-ubiquitination competitive regulatory mechanism that governs S100A11 protein stability, which directly links Warburg effect-derived lactate to oncogenic protein stabilization and metastatic progression in gastric cancer.


  • Open Access

    Primary esophageal marginal zone lymphoma with respiratory symptoms: a case report and review of the literature

    by Xiaoyun Cheng, Wensi Zhang, Minggang Zhang, Shiyu Du

    Background: Primary esophageal lymphoma is a rare disease whose pathogenesis may be related to immune abnormalities. We report a case of primary esophageal marginal zone lymphoma (MZL) in the esophagus for 2 years, which initially presented with respiratory symptoms and was subsequently diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Case presentation: A 68-year-old male presented with a 10-day history of cough, excessive sputum production, and wheezing after physical activity. Two years prior to this admission, the patient had sought medical attention at our hospital for fever and cough. After completing the relevant examinations, the preliminary diagnosis was considered to be a pulmonary infection, with the possibility of an esophageal neoplastic lesion. Upon readmission, a follow-up chest CT revealed thickening of the esophageal wall in multiple segments, which was more pronounced than it had been 2 years previously, and tracheal compression. Upper gastrointestinal endoscopy revealed a widespread, protruding lesion along the entire esophagus, with a smooth mucosal surface and no ulceration. Endoscopic ultrasound revealed the disappearance of the normal layered structure of the esophageal wall at the site of the lesion. PET-CT demonstrated uneven increased radioactive uptake throughout the esophagus. Bone marrow aspiration did not reveal any tumor involvement. Histopathological and immunohistochemical examinations revealed marginal zone lymphoma. Conclusion: Primary esophageal lymphoma has significant clinical heterogeneity, typically starting with progressive dysphagia and weight loss. This patient has a long history of atypical symptoms, representing the first case to present with respiratory symptoms without dysphagia. Due to the extremely low incidence of primary esophageal lymphoma and the lack of typical symptoms, imaging findings, and endoscopic manifestations, it is prone to misdiagnosis. Differential diagnosis is necessary to distinguish it from esophageal malignancies such as esophageal squamous cell carcinoma and esophageal adenocarcinoma, as well as benign esophageal conditions like esophagitis and esophageal tuberculosis. Performing endoscopic ultrasound-guided fine needle aspiration to complete pathological biopsy is crucial to reduce the risk of misdiagnosis and facilitate early diagnosis. Currently, after two courses of the G-CVP regimen (Obinutuzumab + Cyclophosphamide + Vincristine + Prednisone) demonstrated suboptimal efficacy, the treatment was switched to a triple combination of Obinutuzumab, Orelabrutinib, and Lenalidomide, which has now completed six courses.

  • Top Cited Papers
    Open Access

    GastroTCM: a large language model assistant for gastroenterology in traditional Chinese medicine

    by Lan Wang, Kaiqiang Tang, Zhichuan Yang, Yan Wang, Peng Zhang, Bowen Wu, Weibo Zhao, Jun Chen, Jiamin Gong, Shiyu Du, et al.

    Large language models (LLMs) show promise for supporting Traditional Chinese Medicine (TCM) practice, but their clinical utility is limited by domain-specific knowledge gaps, hallucinations, and weak multi-turn reasoning. We present GastroTCM, a specialised LLM assistant for TCM gastroenterology that we built by fine-tuning a Llama3-8B model and augmenting it with a Retrieval-Augmented Generation (RAG) and an agent framework. GastroTCM targets key shortcomings in current TCM diagnostic support through three components: (1) a dedicated TCM gastroenterology vector database for efficient retrieval of high-value, peer-reviewed knowledge; (2) ShareGPT-style multi-turn dialogue optimisation to preserve clinical context across rounds; and (3) an intelligent agent that dynamically adapts its responses to evolving symptom profiles and user intent. GastroTCM was trained on approximately 20 million tokens of de-identified clinical records, guideline-based content, and expert-curated TCM question–answer pairs and evaluated against strong Chinese LLM baselines (ChatGLM-6B, Qwen-2). In automatic evaluations, GastroTCM outperformed all baselines in single-turn dialogue (BLEU: 0.334 vs. 0.172–0.246) and multi-turn consultations, where it achieved a substantially higher rate of proactive, clinically appropriate interactions (27/60 vs. ≤ 2/60 cases). Expert review by TCM gastroenterologists further confirmed higher diagnostic accuracy and safety, with the RAG module markedly reducing unsupported or hallucinated statements. These findings suggest that domain-specific, retrieval-enhanced LLMs can meaningfully augment—rather than replace—TCM practitioners in gastroenterology, with the potential to improve access to high-quality, explainable decision support in real-world settings.


  • Open Access

    Characteristics of gastric fluid microbiota in patients with refractory Helicobacter pylori infection

    by Huiting Zhu, Shijie Sun, Yujing Wang, Wensi Zhang, Shiyu Du, Yanli Zhang

    Introduction: Refractory Helicobacter pylori infection (RHPI) poses a clinical challenge due to its treatment resistance. The gastric microbiota characteristics in patients with RHPI remain unclear. This study analyzed gastric fluid samples to explore the structural and functional differences in the gastric microbiota of patients with RHPI and their association with clinicopathological features, providing a theoretical basis for precision treatment of RHPI.Methods: Eighty-four patients who underwent gastroscopy were prospectively and consecutively divided into the Nhp (H. pylori-negative, n = 32), Php (H. pylori-positive at first diagnosis without treatment, n = 32), and Rhp (RHPI, n = 20) groups. Gastric fluid and mucosal biopsy samples were collected for 16S rRNA gene sequencing, pathological evaluation, and bioinformatic analysis. Differences in gastric microbiota and clinical data were compared among the three groups.Results: The Rhp group exhibited more gastric mucosal atrophy, inflammation, and inflammatory activity than Nhp and Php groups. Rhp also showed lower microbial richness and diversity. β-diversity analysis revealed distinct microbial communities between the Nhp and Php/Rhp groups. Rhp was enriched with H. pylori PZ5004 and Pseudoalteromonas sp. C_8, among others, while Php was enriched with Lactobacillus sp. CY1 and other species and Nhp with Prevotella melaninogenica and other species. The Rhp group also had higher H. pylori PZ5004/P79 abundance, more complex microbial interactions, and enriched sulfur relay pathways than the other groups.Conclusion: H. pylori infection disrupts the diversity, structure, and function of gastric microbiota. The close interaction between characteristic microbiota and H. pylori subspecies may be a key factor contributing to the difficulty in treating RHPI.


  • Fluorinated liquid-crystal monomers distribution in paired urine from mothers and infants

    by Runhui Yang, Yanli Zhang, Qun Gao, Chenhui Sang, Yumin Niu, Shiyu Du, Bing Shao